• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Hasbro, Tutor Perini, Arm Holdings And Other Big Stocks Moving Higher On Friday

    6/14/24 10:29:19 AM ET
    $ADBE
    $ARM
    $ECX
    $GRND
    Computer Software: Prepackaged Software
    Technology
    Semiconductors
    Technology
    Get the next $ADBE alert in real time by email

    U.S. stocks were mostly lower, with the Dow Jones index falling around 300 points on Friday.

    Shares of Hasbro, Inc. (NASDAQ:HAS) rose sharply during Friday's session after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $70 to $80.

    Hasbro shares gained 5.5% to $61.22 on Friday.

    Here are some other big stocks recording gains in today’s session.

    • Disc Medicine, Inc. (NASDAQ:IRON) shares gained 15.6% to $45.29. Disc Medicine announced a $178 million underwritten offering of 4.944 million shares at $36 per share.
    • UroGen Pharma Ltd. (NASDAQ:URGN) rose 15.4% to $20.19. UroGen Pharma recently announced an 82.3% 12-month duration of response in its Phase 3 ENVISION trial for UGN-102, achieving a 79.6% complete response rate at three months.
    • Adobe Inc. (NASDAQ:ADBE) rose surged 14.3% to $524.39 following better-than-expected second-quarter earnings and strong guidance.
    • Ocular Therapeutix, Inc. (NASDAQ:OCUL) rose 14.1% to $5.75 as the company highlighted AXPAXLI SOL-1 enrollment and plans repeat dosing study in wet AMD.
    • VinFast Auto Ltd. (NASDAQ:VFS) climbed 9.9% to $4.32. VinFast Auto anticipates sustained growth for next five years and approaching break-even point.
    • Tutor Perini Corporation (NYSE:TPC) gained 9.9% to $21.11. UBS analyst Steven Fisher upgraded Tutor Perini from Neutral to Buy and raised the price target from $14 to $27.
    • Grindr Inc. (NYSE:GRND) gained 9.2% to $10.30.
    • ECARX Holdings Inc. (NASDAQ:ECX) gained 7.4% to $1.16.
    • Life360, Inc. (NASDAQ:LIF) rose 6.2% to $30.68.
    • Willis Lease Finance Corporation (NASDAQ:WLFC) climbed 6.4% to $64.99.
    • Arm Holdings plc (NASDAQ:ARM) gained 4.4% to $165.07 after it was announced that the company will join the Nasdaq-100 Index starting June 24, 2024.
    • Spotify Technology S.A. (NYSE:SPOT) rose 3.1% to $315.33.
    • Netflix, Inc. (NASDAQ:NFLX) gained 2.9% to $672.08.

    Now Read This: How To Earn $500 A Month From KB Home Stock Ahead Of Q2 Earnings

    Get the next $ADBE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADBE
    $ARM
    $ECX
    $GRND

    CompanyDatePrice TargetRatingAnalyst
    Spotify Technology S.A.
    $SPOT
    2/26/2026$586.00Neutral → Buy
    Arete
    Hasbro Inc.
    $HAS
    2/25/2026$118.00Outperform
    BNP Paribas Exane
    Grindr Inc.
    $GRND
    2/24/2026$14.00Equal-Weight
    Morgan Stanley
    Spotify Technology S.A.
    $SPOT
    2/11/2026$875.00 → $420.00Buy → Hold
    Pivotal Research Group
    Arm Holdings plc
    $ARM
    2/5/2026Neutral → Buy
    New Street
    Adobe Inc.
    $ADBE
    2/3/2026$330.00Overweight → Neutral
    Piper Sandler
    Spotify Technology S.A.
    $SPOT
    1/30/2026$650.00Neutral → Buy
    Citigroup
    Spotify Technology S.A.
    $SPOT
    1/27/2026$487.00Neutral
    MoffettNathanson
    More analyst ratings

    $ADBE
    $ARM
    $ECX
    $GRND
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lindstrom Richard L Md bought $461,354 worth of shares (60,229 units at $7.66), increasing direct ownership by 32% to 246,933 units (SEC Form 4)

    4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)

    2/24/26 6:13:03 PM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Zage George Raymond Iii bought $675,500 worth of shares (50,000 units at $13.51), increasing direct ownership by 0.62% to 8,113,283 units (SEC Form 4)

    4 - Grindr Inc. (0001820144) (Issuer)

    12/9/25 6:47:20 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    Director Zage George Raymond Iii bought $2,091,000 worth of shares (155,000 units at $13.49), increasing direct ownership by 1% to 8,063,283 units (SEC Form 4)

    4 - Grindr Inc. (0001820144) (Issuer)

    12/5/25 5:00:05 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    $ADBE
    $ARM
    $ECX
    $GRND
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Dugel Pravin sold $166,064 worth of shares (20,056 units at $8.28), decreasing direct ownership by 0.66% to 3,013,022 units (SEC Form 4)

    4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)

    2/25/26 6:20:23 PM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Development Officer Kaiser Peter sold $23,267 worth of shares (2,810 units at $8.28), decreasing direct ownership by 1% to 269,108 units (SEC Form 4)

    4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)

    2/25/26 6:19:11 PM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Scientific Officer Heier Jeffrey S. sold $25,312 worth of shares (3,057 units at $8.28), decreasing direct ownership by 0.94% to 323,368 units (SEC Form 4)

    4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)

    2/25/26 6:18:30 PM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $ARM
    $ECX
    $GRND
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Netflix CFO to Participate in a Q&A session at the Morgan Stanley Technology, Media & Telecom Conference

    LOS GATOS, Calif., Feb. 25, 2026 /PRNewswire/ -- Netflix, Inc. (NASDAQ:NFLX) announced today that its CFO Spence Neumann will participate in a Q&A session at the Morgan Stanley Technology, Media & Telecom Conference on Wednesday, March 4, 2026. Mr. Neumann is scheduled to present at 1:50 p.m. Pacific Time / 4:50 p.m. Eastern Time. A live webcast and replay of the presentation will be available on the Netflix investor relations website at http://ir.netflix.net.   About Netflix, Inc.Netflix is one of the world's leading entertainment services offering TV series, films, games and l

    2/25/26 12:00:00 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Grindr to Participate in Upcoming Investor Conferences

    Grindr Inc. (NYSE:GRND), the Global Gayborhood in Your Pocket™, today announced participation in the following upcoming investor events. Morgan Stanley Technology, Media & Telecom Conference Location: San Francisco, CA Date: Monday, March 2, 2026 Fireside Chat Presentation: 12:20 PM PT Speaker: Chief Executive Officer, George Arison Citizens Technology Conference Location: San Francisco, CA Date: Tuesday, March 3, 2026 Fireside Chat Presentation: 11:30 AM PT Speaker: Chief Financial Officer, John Moore A live webcast of each fireside chat will be made available on Grindr's investor relations website at https://investors.grindr.com/. An archived replay of each webcast will be avail

    2/25/26 8:00:00 AM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    PARAMOUNT COMMENTS ON WARNER BROS. DISCOVERY BOARD'S DETERMINATION THAT PARAMOUNT PROPOSAL COULD REASONABLY BE EXPECTED TO LEAD TO A SUPERIOR PROPOSAL

    LOS ANGELES and NEW YORK, Feb. 24, 2026 /PRNewswire/ -- Paramount Skydance Corporation (NASDAQ:PSKY) ("Paramount") issued the following statement in response to the announcement by Warner Bros. Discovery, Inc. (NASDAQ:WBD) ("WBD") that WBD's Board of Directors has determined that Paramount's revised $31 per share, all-cash offer to acquire WBD could reasonably be expected to lead to a "Company Superior Proposal" under the terms of WBD's merger agreement with Netflix, Inc. (NASDAQ:NFLX): Paramount welcomes the WBD Board's determination and looks forward to continuing to engage constructively with WBD to deliver the benefits of Paramount's proposal to WBD shareholders, the creative community a

    2/24/26 8:27:00 PM ET
    $NFLX
    $PSKY
    $WBD
    Consumer Electronics/Video Chains
    Consumer Discretionary
    Broadcasting
    Industrials

    $ADBE
    $ARM
    $ECX
    $GRND
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Spotify upgraded by Arete with a new price target

    Arete upgraded Spotify from Neutral to Buy and set a new price target of $586.00

    2/26/26 7:10:22 AM ET
    $SPOT
    Broadcasting
    Consumer Discretionary

    BNP Paribas Exane initiated coverage on Hasbro with a new price target

    BNP Paribas Exane initiated coverage of Hasbro with a rating of Outperform and set a new price target of $118.00

    2/25/26 8:51:16 AM ET
    $HAS
    Recreational Games/Products/Toys
    Consumer Discretionary

    Morgan Stanley initiated coverage on Grindr with a new price target

    Morgan Stanley initiated coverage of Grindr with a rating of Equal-Weight and set a new price target of $14.00

    2/24/26 7:55:00 AM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    $ADBE
    $ARM
    $ECX
    $GRND
    SEC Filings

    View All

    SEC Form 144 filed by Disc Medicine Inc.

    144 - Disc Medicine, Inc. (0001816736) (Subject)

    2/25/26 4:29:47 PM ET
    $IRON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Hasbro Inc.

    10-K - HASBRO, INC. (0000046080) (Filer)

    2/25/26 4:11:58 PM ET
    $HAS
    Recreational Games/Products/Toys
    Consumer Discretionary

    Grindr Inc. filed SEC Form 8-K: Shareholder Director Nominations, Financial Statements and Exhibits

    8-K - Grindr Inc. (0001820144) (Filer)

    2/24/26 4:08:31 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    $ADBE
    $ARM
    $ECX
    $GRND
    Leadership Updates

    Live Leadership Updates

    View All

    Edgewater Wireless Issues 2026 Corporate Update

    "Wi-Fi8 Before Wi-Fi8" – Accelerating Wi-Fi8-ready Spectrum Slicing™ Silicon with Silicon Catalyst Ecosystem, Arm, Synopsys and FABrIC Support Edgewater Wireless Systems Inc. (TSXV:YFI) (OTC:KPIFF), the industry pioneer of AI-powered Wi-Fi Spectrum Slicing™ silicon solutions and IP for residential, enterprise and Industrial IoT markets, today issued a corporate update outlining the Company's material progress over the past 12 months and its 2026 execution roadmap toward Wi-Fi8-ready silicon deliverables and strategic commercialization. Over the last year, Edgewater has evolved from an innovation-led Wi-Fi disruptor into a globally recognized reliability and low-latency thought leader, a

    2/5/26 7:01:00 AM ET
    $ARM
    $SNPS
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    Willis Lease Finance Corporation Welcomes Steven Bridgland as Head of Investor Relations & Capital Markets for Willis Aviation Capital

    COCONUT CREEK, Fla., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation (NASDAQ:WLFC) ("WLFC" or the "Company"), the leading lessor of commercial aircraft engines and a global provider of aviation services, today announced the appointment of Steven Bridgland as Head of Investor Relations & Capital Markets for its recently announced asset manager, Willis Aviation Capital. In this role, Steve will lead day-to-day management of Willis Aviation Capital's existing investor relationships, continue development of new investor relationships and support capital deployment efforts. With more than three decades of experience, Steve brings extensive expertise in equity and debt capita

    1/22/26 8:25:00 AM ET
    $WLFC
    Industrial Specialties
    Consumer Discretionary

    Ocular Therapeutix™ Appoints David W. Robinson as Global Chief Commercial Officer

    Accomplished global commercial leader with deep expertise in retina drug launches Primary architect for the industry-defining launch of EYLEA® while at Regeneron Most recently served as Chief Marketing Officer, Global Ophthalmology at Merck BEDFORD, Mass., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular")), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that David W. Robinson has agreed to join the Company as Global Chief Commercial Officer. The appointment of Mr. Robinson, a proven commercial leader with a history of launching category-defining therapies, strategically positions Ocular for success

    1/21/26 7:00:00 AM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $ARM
    $ECX
    $GRND
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Grindr Inc.

    SC 13D/A - Grindr Inc. (0001820144) (Subject)

    12/9/24 5:32:00 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13D/A filed by UroGen Pharma Ltd.

    SC 13D/A - UroGen Pharma Ltd. (0001668243) (Subject)

    11/18/24 6:16:04 AM ET
    $URGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by UroGen Pharma Ltd.

    SC 13G/A - UroGen Pharma Ltd. (0001668243) (Subject)

    11/14/24 7:46:37 PM ET
    $URGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $ARM
    $ECX
    $GRND
    Financials

    Live finance-specific insights

    View All

    UroGen Pharma to Report Fourth Quarter and Full-Year 2025 Financial Results on Monday, March 2, 2026

    PRINCETON, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ:URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will report fourth quarter and full-year 2025 financial results on Monday, March 2nd , 2026, prior to the open of the stock market. The announcement will be followed by a live audio webcast and conference call at 10:00 AM Eastern Time. A live public webcast of the earnings conference call can be accessed on UroGen's Investor Relations website. Following the live webcast, a replay will be available on the site for approximately 30 days. About UroGen Pharma

    2/23/26 8:00:00 AM ET
    $URGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ocular Therapeutix™ to Present Detailed SOL-1 Data at the 49th Macula Society Annual Meeting and Host Investor Webcast to Discuss Presentations

    Ocular to present detailed SOL-1 data at the 49th Macula Society Annual Meeting on Friday, February 27, 2026, starting at 1:00 PM PT (4:00 PM ET) Company to host an investor webcast on Monday, March 2, 2026, at 7:30 AM ET to discuss the Macula Society presentations BEDFORD, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular")), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that the Company will present detailed results from the SOL-1 Phase 3 superiority clinical trial of AXPAXLI™ (also known as OTX-TKI), for the treatment of wet age-related macular degeneration (wet AMD), at the 49th Macula Soc

    2/23/26 7:00:00 AM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tutor Perini Announces Conference Call to Discuss Fourth Quarter and Full Year 2025 Results

    Tutor Perini Corporation (NYSE:TPC) (the "Company"), a leading civil, building and specialty construction company, announced today that it will host a conference call at 2:00 PM Pacific Time on Thursday, February 26, 2026, to discuss the Company's fourth quarter and full year 2025 results. Participants on the call from Tutor Perini will be Gary Smalley, CEO and President; Ryan Soroka, Executive Vice President and CFO; and Ronald Tutor, Executive Chairman. The Company plans to issue its earnings announcement the same day after the market close. To participate in the conference call, please dial 877-407-8293 five to ten minutes prior to the scheduled time. International callers should dia

    2/18/26 6:00:00 PM ET
    $TPC
    General Bldg Contractors - Nonresidential Bldgs
    Consumer Discretionary